These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16622989)

  • 1. Using our best judgment in conducting human research.
    Sieber JE
    Ethics Behav; 2004; 14(4):297-304. PubMed ID: 16622989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Empirical research on research ethics.
    Sieber JE
    Ethics Behav; 2004; 14(4):397-412. PubMed ID: 16625736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human participants challenges in youth tobacco cessation research: researchers' perspectives.
    Diviak KR; Curry SJ; Emery SL; Mermelstein RJ
    Ethics Behav; 2004; 14(4):321-34. PubMed ID: 16625727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is compliance a professional virtue of researchers? Reflections on promoting the responsible conduct of research.
    DuBois JM
    Ethics Behav; 2004; 14(4):383-95. PubMed ID: 16625734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Federal commissions and local IRBs.
    Yesley MS
    Hastings Cent Rep; 1983 Oct; 13(5):11-2. PubMed ID: 6643032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human participants challenges in youth-focused research: perspectives and practices of IRB administrators.
    Wagener DK; Sporer AK; Simmerling M; Flome JL; An C; Curry SJ
    Ethics Behav; 2004; 14(4):335-49. PubMed ID: 16625728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethics review of social, behavioral, and economic research: where should we go from here?
    De Vries R; DeBruin DA; Goodgame A
    Ethics Behav; 2004; 14(4):351-68. PubMed ID: 16625729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Researcher liability for negligence in human subject research: informed consent and researcher malpractice actions.
    Jansson RL
    Wash Law Rev; 2003 Feb; 78(1):229-63. PubMed ID: 15732212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nanny state meets the inner lawyer: overregulating while underprotecting human participants in research.
    Gunsalus CK
    Ethics Behav; 2004; 14(4):369-82. PubMed ID: 16625733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changing federal regulation of IRBs, Part III: social research and the proposed DHEW regulations.
    Gray BH
    IRB; 1980 Jan; 2(1):1-5+. PubMed ID: 11661793
    [No Abstract]   [Full Text] [Related]  

  • 11. Ethical and regulatory challenges associated with the exception from informed consent requirements for emergency research: from experimental design to institutional review board approval.
    Vaslef SN; Cairns CB; Falletta JM
    Arch Surg; 2006 Oct; 141(10):1019-23; discussion 1024. PubMed ID: 17043281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conducting industrial and organizational psychological research: institutional review of research in work organizations.
    Ilgen DR; Bell BS
    Ethics Behav; 2001; 11(4):395-412. PubMed ID: 11838504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research consent by adolescent minors and institutional review boards.
    Mammel KA; Kaplan DW
    J Adolesc Health; 1995 Nov; 17(5):323-30. PubMed ID: 8924437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The purpose, composition, and function of an institutional review board: balancing priorities.
    Enfield KB; Truwit JD
    Respir Care; 2008 Oct; 53(10):1330-6. PubMed ID: 18811996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to do human-subjects research if you do not have an institutional review board.
    Rice TW
    Respir Care; 2008 Oct; 53(10):1362-7. PubMed ID: 18812001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exception from informed consent: viewpoint of institutional review boards--balancing risks to subjects, community consultation, and future directions.
    Ernst AA; Fish S
    Acad Emerg Med; 2005 Nov; 12(11):1050-5. PubMed ID: 16264073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of warning letters issued to institutional review boards by the United States Food and Drug Administration.
    Bramstedt KA; Kassimatis K
    Clin Invest Med; 2004 Dec; 27(6):316-23. PubMed ID: 15675112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The institutional review board.
    Hart R; Belotto M
    Semin Nucl Med; 2010 Sep; 40(5):385-92. PubMed ID: 20674597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Harmonizing regulations for biomedical research: a critical analysis of the US and Venezuelan systems.
    Di Tillio-Gonzalez D; Fischbach RL
    Dev World Bioeth; 2008 Dec; 8(3):167-77. PubMed ID: 17488491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.